Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Recombinant Protein / Other Proteins

Recombinant Human HLA-B Protein, N-His

Catalog #:   YHB96301 Specific References (50) DATASHEET
Applications: ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Expression system: E. coli
Accession: P01889
Protein length: Ser26-Val309
Overview

Catalog No.

YHB96301

Expression system

E. coli

Species

Homo sapiens (Human)

Protein length

Ser26-Val309

Predicted molecular weight

35.17 kDa

Nature

Recombinant

Endotoxin level

Please contact with the lab for this information.

Purity

>90% as determined by SDS-PAGE.

Accession

P01889

Applications

ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress

Form

Lyophilized

Storage buffer

Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.

Reconstitution

Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.

Shipping

In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Alternative Names

HLA-B, HLA class I histocompatibility antigen, B alpha chain, Human leukocyte antigen B, HLAB

Data Image
  • SDS-PAGE
    SDS PAGE for recombinant Human HLA-B protein
References

Granulocyte-macrophage colony-stimulating factor may contribute to spondyloarthritis development in HLA-B27 transgenic rat by affecting conventional dendritic cells function., PMID:40514729

Acute Lymphoblastic Leukemia and Associated HLA-A, B, DRB1, and DQB1 Molecules: A Moroccan Pediatric Case-Control Study., PMID:40508101

Characterization of HLA-A/HLA-B/HLA-C/HLA-DRB1 Haplotypes in Romanian Stem Cell Donors Through High-Resolution Next-Generation Sequencing., PMID:40508057

Predominant T-cell epitopes of SARS-CoV-2 restricted by multiple prevalent HLA-B and HLA-C allotypes in Northeast Asia., PMID:40469303

Asymptomatic SARS-CoV-2 Infection: Association Involving the HLA-B*15 Allele Group in Brazilian Individuals., PMID:40451247

Successful treatment with tocilizumab in a case of familial Mediterranean fever with Takayasu arteritis., PMID:40433865

Expanding the Genetic Framework: Insights into Non-HLA-B27 Contributions to Axial Spondylarthritis., PMID:40428751

Uncovering dendritic cell specific biomarkers for diagnosis and prognosis of cardiomyopathy using single cell RNA sequencing and comprehensive bioinformatics analysis., PMID:40419517

Engaging T cells for cleanup., PMID:40416957

ESMpHLA: Evolutionary Scale Model-Based Deep Learning Prediction of HLA Class I Binding Peptides., PMID:40405507

Identification of the Novel HLA-B*55:141 Allele in a Chinese Individual., PMID:40391881

Shared neoantigens' atlas for off-the-shelf cancer vaccine development., PMID:40390041

CD28 and CTLA4 polymorphisms associated with ankylosing spondylitis: a study in the context of HLA-B27., PMID:40389847

Identification of the Novel HLA-B Allele HLA-B*13:01:01:12 in Two Individuals From South India., PMID:40376913

Characterisation of Novel HLA-B*37:119 in Indian Individual by Next Generation Sequencing., PMID:40371937

HLA Polymorphisms and COVID-19 Susceptibility and Severity: Insights From an Iranian Patients Cohort., PMID:40366340

Seven New Non-Synonymous Alleles of HLA-B Characterised by Next-Generation Sequencing., PMID:40364566

Regional distribution of HLA frequencies in the USA: implications for TCR-based therapies., PMID:40360437

High prevalence of HLA-B51 and ocular involvement in Behçet's disease: a multicenter cross-sectional study., PMID:40349258

Case Report: Ankylosing Spondylitis Complicated With Systemic Lupus Erythematosus., PMID:40349144

Low Frequency of HLA-B27 in Ankylosing Spondylitis Patients from Turkey: Insights from the Thrace Region., PMID:40346789

Deletion of the HLA-B Gene in One of the Inherited Haplotypes in a Northern European Family., PMID:40345160

Detection of the HLA-B*54:21 Allele, a Variant of B*54:01:01:01, in a Taiwanese Individual., PMID:40344615

The Novel HLA-B Allele, HLA-B*35:629N Was Identified in a Chinese Individual., PMID:40344381

Identification of the Novel HLA-B*40:160:01:02 Allele., PMID:40343444

Differential reactivity of SARS-CoV-2 S-protein T-cell epitopes in vaccinated versus naturally infected individuals., PMID:40342296

[Identification of the Novel Allele HLA-B*54:01:11 Detected by NGS Using the Third Generation Sequencing Technology]., PMID:40326135

The rapid detection of human HLA-B*27 gene based on BASIC isothermal detection., PMID:40316660

HLA B subtype analysis in patients developing tuberculosis during anti-TNF treatment., PMID:40307303

Proteomic Profiling of Inflammatory Protein Dysregulation in HLA-B27-Positive Ankylosing Spondylitis: Molecular Signatures and Potential Biomarkers., PMID:40305235

Two New Alleles, HLA-B*40:06:01:20 and HLA-DRB1*09:61N, Detected in a Spanish Bone Marrow Donor., PMID:40304196

HLA alleles and dengue susceptibility across populations in the era of climate change: a comprehensive review., PMID:40303409

Detection of the HLA-B*15:88 Allele in a Taiwanese Individual., PMID:40302456

Integrated multi-omics insight into the molecular networks of oxidative stress in triggering multiple sclerosis., PMID:40280189

Discovery of an HLA-B*35 Null Variant, HLA-B*35:636N in Two Unrelated Individuals., PMID:40275475

Characterisation of the Novel HLA-B*48:43:02 Allele in a Chinese Individual., PMID:40270225

Identification of the Nine Novel HLA-B Alleles in Individuals From Russia., PMID:40270159

Identification of Five New HLA-B Silent Variants by Next-Generation Sequencing., PMID:40270086

The Novel HLA-B*40:01:92 Allele Identified in Patient and His Related Donor., PMID:40270015

HLA-B51 Positivity Correlates With Symptom Completeness From Recurrent Aphthous Stomatitis to Complete Behçet's Disease., PMID:40257074

Identification of the Novel HLA-B*38:125 Allele by Next-Generation Sequencing., PMID:40251932

Enhancing the Anticancer Activity of a Carcinoma-Directed Peptide-HLA-I Fusion Protein by Armoring with Mutein IFNα., PMID:40243928

HLA Class I and II allelic diversity among Ecuadorian transplant candidates: A comprehensive retrospective analysis., PMID:40239304

Altered maturation and activation state of circulating monocytes is associated with their enhanced recruitment in pulmonary arterial hypertension., PMID:40234964

Identification of the Novel HLA-B*49:01:01:23 Allele by Sequencing-Based Typing., PMID:40233946

Demographics and clinical manifestations in patients with Behçet's disease: a retrospective observational study from a non-endemic country., PMID:40232346

Detection of the HLA-B*27:247 Allele in Two Taiwanese Siblings., PMID:40231649

Selective Deletion of HLA-B, and -C Class I Genes Promotes Immunocompatibility of Humanized Skin Graft Model., PMID:40230599

The Novel HLA-Β Allele, HLA-B*18:05:01:03, Identified by Next-Generation Sequencing in a Greek Individual., PMID:40207370

The HLA-B*39:01:01:31 Allele Identified by Next Generation Sequencing in an Asian Voluntary Bone Marrow Donor., PMID:40194949

Datasheet
$ 313
Product specifications
100 μg 313 1 mg 1629

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Recombinant Human HLA-B Protein, N-His [YHB96301]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only